TITLE:
Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose Control

CONDITION:
Diabetes Mellitus, Type 1

INTERVENTION:
Pramlintide acetate

SUMMARY:

      This is a randomized, triple-blind, placebo-controlled, multicenter study to investigate the
      safety of pramlintide treatment using pramlintide dose-titration coupled with insulin
      adjustments in subjects with type 1 diabetes who are actively trying to improve their
      glycemic control.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  HbA1c value between 7.5-9%

          -  Using multiple daily insulin injections
      
